Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk

Clusterin (CLU) is an extracellular chaperone involved in reducing amyloid beta (Aβ) toxicity and aggregation. Although previous genome-wide association studies (GWAS) have reported a potential protective effect of CLU on Alzheimer’s disease (AD) patients, how intron-located rs11136000 (CLU) affects...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jin, Qiu, Shizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407972/
https://www.ncbi.nlm.nih.gov/pubmed/36033622
http://dx.doi.org/10.3389/fnins.2022.926830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407972/
https://www.ncbi.nlm.nih.gov/pubmed/36033622
http://dx.doi.org/10.3389/fnins.2022.926830

Ejemplares similares